| 1 | Baseline epitope-specific IgE profiles are predictive of sustained unresponsiveness or high threshold 1-year post oral immunotherapy in the POISED trial | 6.2 | 4 | Citations (PDF) |
| 2 | Utility of epitope-specific IgE, IgG4, and IgG1 antibodies for the diagnosis of wheat allergy | 6.2 | 9 | Citations (PDF) |
| 3 | Scaleable production of highly loaded protein nanoparticles for immune modulation | 8.2 | 5 | Citations (PDF) |
| 4 | Allergen recognition by specific effector Th2 cells enables <scp>IL</scp>‐2‐dependent activation of regulatory T‐cell responses in humans | 9.5 | 28 | Citations (PDF) |
| 5 | Peanut Can Be Used as a Reference Allergen for Hazard Characterization in Food Allergen Risk Management: A Rapid Evidence Assessment and Meta-Analysis | 3.3 | 34 | Citations (PDF) |
| 6 | Anaphylaxis knowledge gaps and future research priorities: A consensus report | 6.2 | 36 | Citations (PDF) |
| 7 | Bringing the Next Generation of Food Allergy Diagnostics Into the Clinic | 3.3 | 57 | Citations (PDF) |
| 8 | Allergen-specific T cells and clinical features of food allergy: Lessons from CoFAR immunotherapy cohorts | 6.2 | 47 | Citations (PDF) |
| 9 | Proposal of 0.5 mg of protein/100 g of processed food as threshold for voluntary declaration of food allergen traces in processed food—A first step in an initiative to better inform patients and avoid fatal allergic reactions: A GA²LEN position paper | 9.5 | 33 | Citations (PDF) |
| 10 | Safety of Epicutaneous Immunotherapy in Peanut-Allergic Children: REALISE Randomized Clinical Trial Results | 3.3 | 53 | Citations (PDF) |
| 11 | Efficacy and safety of oral immunotherapy in children aged 1–3 years with peanut allergy (the Immune Tolerance Network IMPACT trial): a randomised placebo-controlled study | 52.8 | 281 | Citations (PDF) |
| 12 | Allergen immunotherapy and/or biologicals for IgE‐mediated food allergy: A systematic review and meta‐analysis | 9.5 | 128 | Citations (PDF) |
| 13 | HLA alleles and sustained peanut consumption promote IgG4 responses in subjects protected from peanut allergy | 10.7 | 25 | Citations (PDF) |
| 14 | Updated threshold dose‐distribution data for sesame | 9.5 | 8 | Citations (PDF) |
| 15 | Reproducibility of food challenge to cow’s milk: Systematic review with individual participant data meta-analysis | 6.2 | 21 | Citations (PDF) |
| 16 | Food-specific immunoglobulin A does not correlate with natural tolerance to peanut or egg allergens | 12.7 | 32 | Citations (PDF) |
| 17 | Epicutaneous immunotherapy for treatment of peanut allergy: Follow-up from the Consortium for Food Allergy Research | 6.2 | 50 | Citations (PDF) |
| 18 | Sustained unresponsiveness to peanut after long-term peanut epicutaneous immunotherapy | 3.3 | 14 | Citations (PDF) |
| 19 | Profiling serum antibodies with a pan allergen phage library identifies key wheat allergy epitopes | 13.9 | 52 | Citations (PDF) |
| 20 | bbeaR: an R package and framework for epitope-specific antibody profiling | 4.8 | 2 | Citations (PDF) |
| 21 | A novel approach to the basophil activation test for characterizing peanut allergic patients in the clinical setting | 9.5 | 12 | Citations (PDF) |
| 22 | Accurate and reproducible diagnosis of peanut allergy using epitope mapping | 9.5 | 74 | Citations (PDF) |
| 23 | Using data from food challenges to inform management of consumers with food allergy: A systematic review with individual participant data meta-analysis | 6.2 | 60 | Citations (PDF) |
| 24 | Severity grading system for acute allergic reactions: A multidisciplinary Delphi study | 6.2 | 120 | Citations (PDF) |
| 25 | Evolution of epitope-specific IgE and IgG4 antibodies in children enrolled in the LEAP trial | 6.2 | 58 | Citations (PDF) |
| 26 | A Historical Perspective on the Substantial Progress in Understanding Eosinophilic Gastrointestinal Disease | 3.3 | 0 | Citations (PDF) |
| 27 | Epicutaneous immunotherapy protects cashew‐sensitized mice from anaphylaxis | 9.5 | 17 | Citations (PDF) |
| 28 | Food allergy across the globe | 6.2 | 267 | Citations (PDF) |
| 29 | Are avoidance diets still warranted in children with atopic dermatitis? | 2.8 | 47 | Citations (PDF) |
| 30 | IgE and IgG4 binding to lentil epitopes in children with red and green lentil allergy | 2.8 | 21 | Citations (PDF) |
| 31 | A 5-year summary of real-life dietary egg consumption after completion of a 4-year egg powder oral immunotherapy (eOIT) protocol | 6.2 | 14 | Citations (PDF) |
| 32 | Dual transcriptomic and epigenomic study of reaction severity in peanut-allergic children | 6.2 | 68 | Citations (PDF) |
| 33 | Diagnosis of Sesame Allergy: Analysis of Current Practice and Exploration of Sesame Component Ses i 1 | 3.3 | 36 | Citations (PDF) |
| 34 | Early epitope-specific IgE antibodies are predictive of childhood peanut allergy | 6.2 | 53 | Citations (PDF) |
| 35 | Induction of sustained unresponsiveness after egg oral immunotherapy compared to baked egg therapy in children with egg allergy | 6.2 | 71 | Citations (PDF) |
| 36 | Managing Food Allergy in Schools During the COVID-19 Pandemic | 3.3 | 28 | Citations (PDF) |
| 37 | Persistent, refractory, and biphasic anaphylaxis: A multidisciplinary Delphi study | 6.2 | 79 | Citations (PDF) |
| 38 | Ovomucoid epitope‐specific repertoire of IgE, IgG<sub>4</sub>, IgG<sub>1</sub>, IgA<sub>1</sub>, and IgD antibodies in egg‐allergic children | 9.5 | 32 | Citations (PDF) |
| 39 | A WAO — ARIA — GA2LEN consensus document on molecular-based allergy diagnosis (PAMD@): Update 2020 | 4.0 | 113 | Citations (PDF) |
| 40 | Long-term, open-label extension study of the efficacy and safety of epicutaneous immunotherapy for peanut allergy in children: PEOPLE 3-year results | 6.2 | 89 | Citations (PDF) |
| 41 | A new Luminex‐based peptide assay to identify reactivity to baked, fermented, and whole milk | 9.5 | 45 | Citations (PDF) |
| 42 | Deriving individual threshold doses from clinical food challenge data for population risk assessment of food allergens | 6.2 | 50 | Citations (PDF) |
| 43 | A Phase 2 Randomized Controlled Multisite Study Using Omalizumab-facilitated Rapid Desensitization to Test Continued vs Discontinued Dosing in Multifood Allergic Individuals | 8.5 | 118 | Citations (PDF) |
| 44 | Clinical factors associated with peanut allergy in a high‐risk infant cohort | 9.5 | 24 | Citations (PDF) |
| 45 | Utilizing boiled milk sIgE as a predictor of baked milk tolerance in cow's milk allergic children | 3.3 | 5 | Citations (PDF) |
| 46 | The Consortium for Food Allergy Research (CoFAR): The first generation | 6.2 | 25 | Citations (PDF) |
| 47 | Novel Bead-Based Epitope Assay is a sensitive and reliable tool for profiling epitope-specific antibody repertoire in food allergy | 3.5 | 60 | Citations (PDF) |
| 48 | Predicting development of sustained unresponsiveness to milk oral immunotherapy using epitope-specific antibody binding profiles | 6.2 | 79 | Citations (PDF) |
| 49 | Diagnosing Peanut Allergy with Fewer Oral Food Challenges | 3.3 | 36 | Citations (PDF) |
| 50 | B‐cell phenotype and function in infants with egg allergy | 9.5 | 9 | Citations (PDF) |
| 51 | Multicenter, randomized, double-blind, placebo-controlled clinical trial of vital wheat gluten oral immunotherapy | 6.2 | 87 | Citations (PDF) |
| 52 | Phenotypes and endotypes of food allergy: A path to better understanding the pathogenesis and prognosis of food allergy | 1.1 | 43 | Citations (PDF) |
| 53 | Single-cell profiling of peanut-responsive T cells in patients with peanut allergy reveals heterogeneous effector TH2 subsets | 6.2 | 113 | Citations (PDF) |
| 54 | Safety and efficacy of epicutaneous immunotherapy for food allergy | 2.8 | 51 | Citations (PDF) |
| 55 | Increased Tolerance to Less Extensively Heat-Denatured (Baked) Milk Products in Milk-Allergic Children | 3.3 | 59 | Citations (PDF) |
| 56 | Food allergy: A review and update on epidemiology, pathogenesis, diagnosis, prevention, and management | 6.2 | 1,404 | Citations (PDF) |
| 57 | Treatment for food allergy | 6.2 | 162 | Citations (PDF) |
| 58 | Food allergy | 50.7 | 341 | Citations (PDF) |
| 59 | Mechanisms of food allergy | 6.2 | 283 | Citations (PDF) |
| 60 | Food allergy: Update on prevention and tolerance | 6.2 | 129 | Citations (PDF) |
| 61 | Egg-specific IgE and basophil activation but not egg-specific T-cell counts correlate with phenotypes of clinical egg allergy | 6.2 | 49 | Citations (PDF) |
| 62 | Effect of traditional Chinese medicine on skin lesions and quality of life in patients with moderate to severe eczema | 1.1 | 10 | Citations (PDF) |
| 63 | Outcomes of 84 consecutive open food challenges to extensively heated (baked) milk in the allergy office | 3.3 | 17 | Citations (PDF) |
| 64 | Is Skin Testing or sIgE Testing Necessary Before Early Introduction of Peanut for Prevention of Peanut Allergy? | 3.3 | 6 | Citations (PDF) |
| 65 | PDL2+ CD11b+ dermal dendritic cells capture topical antigen through hair follicles to prime LAP+ Tregs | 13.9 | 72 | Citations (PDF) |
| 66 | Secreted IgD Amplifies Humoral T Helper 2 Cell Responses by Binding Basophils via Galectin-9 and CD44 | 23.3 | 95 | Citations (PDF) |
| 67 | Phenotypic Characterization of Eosinophilic Esophagitis in a Large Multicenter Patient Population from the Consortium for Food Allergy Research | 3.3 | 113 | Citations (PDF) |
| 68 | Genetic variants at the 16p13 locus confer risk for eosinophilic esophagitis | 3.8 | 41 | Citations (PDF) |
| 69 | Epicutaneous immunotherapy induces gastrointestinal LAP + regulatory T cells and prevents food-induced anaphylaxis | 6.2 | 138 | Citations (PDF) |
| 70 | Addendum guidelines for the prevention of peanut allergy in the United States: Report of the National Institute of Allergy and Infectious Diseases–sponsored expert panel | 6.2 | 444 | Citations (PDF) |
| 71 | Addendum Guidelines for the Prevention of Peanut Allergy in the United States: Report of the National Institute of Allergy and Infectious Diseases–Sponsored Expert Panel | 2.1 | 15 | Citations (PDF) |
| 72 | Addendum Guidelines for the Prevention of Peanut Allergy in the United States: Report of the National Institute of Allergy and Infectious Diseases–Sponsored Expert Panel | 1.1 | 22 | Citations (PDF) |
| 73 | Patterns of immune development in urban preschoolers with recurrent wheeze and/or atopy | 6.2 | 26 | Citations (PDF) |
| 74 | Addendum guidelines for the prevention of peanut allergy in the United States | 1.1 | 17 | Citations (PDF) |
| 75 | International consensus guidelines for the diagnosis and management of food protein–induced enterocolitis syndrome: Executive summary—Workgroup Report of the Adverse Reactions to Foods Committee, American Academy of Allergy, Asthma & Immunology | 6.2 | 634 | Citations (PDF) |
| 76 | Mechanistic correlates of clinical responses to omalizumab in the setting of oral immunotherapy for milk allergy | 6.2 | 60 | Citations (PDF) |
| 77 | Impact of granulocyte contamination on PBMC integrity of shipped blood samples: Implications for multi-center studies monitoring regulatory T cells | 1.5 | 12 | Citations (PDF) |
| 78 | Dietary isoflavone supplementation for food allergy: A pilot study | 3.3 | 6 | Citations (PDF) |
| 79 | Partially hydrolyzed whey formula intolerance in cow's milk allergic patients | 2.8 | 12 | Citations (PDF) |
| 80 | Alterations in B-cell subsets in pediatric patients with early atopic dermatitis | 6.2 | 50 | Citations (PDF) |
| 81 | Addendum guidelines for the prevention of peanut allergy in the United States: Report of the National Institute of Allergy and Infectious Diseases–sponsored expert panel | 1.1 | 66 | Citations (PDF) |
| 82 | Immunology of Food Allergy | 23.3 | 293 | Citations (PDF) |
| 83 | Effect of Varying Doses of Epicutaneous Immunotherapy vs Placebo on Reaction to Peanut Protein Exposure Among Patients With Peanut Sensitivity | 17.1 | 210 | Citations (PDF) |
| 84 | Epicutaneous immunotherapy for the treatment of peanut allergy in children and young adults | 6.2 | 298 | Citations (PDF) |
| 85 | Patch testing of food allergens promotes Th17 and Th2 responses with increased <scp>IL</scp>‐33: a pilot study | 2.8 | 13 | Citations (PDF) |
| 86 | The false alarm hypothesis: Food allergy is associated with high dietary advanced glycation end-products and proglycating dietary sugars that mimic alarmins | 6.2 | 118 | Citations (PDF) |
| 87 | Humoral and cellular responses to casein in patients with food protein–induced enterocolitis to cow's milk | 6.2 | 100 | Citations (PDF) |
| 88 | Transcriptional Profiling of Egg Allergy and Relationship to Disease Phenotype | 2.4 | 35 | Citations (PDF) |
| 89 | What Characteristics Confer Proteins the Ability to Induce Allergic Responses? IgE Epitope Mapping and Comparison of the Structure of Soybean 2S Albumins and Ara h 2 | 4.3 | 21 | Citations (PDF) |
| 90 | AllergenOnline: A peer‐reviewed, curated allergen database to assess novel food proteins for potential cross‐reactivity | 4.1 | 222 | Citations (PDF) |
| 91 | Investigation of peanut oral immunotherapy with CpG/peanut nanoparticles in a murine model of peanut allergy | 6.2 | 101 | Citations (PDF) |
| 92 | Long-term treatment with egg oral immunotherapy enhances sustained unresponsiveness that persists after cessation of therapy | 6.2 | 169 | Citations (PDF) |
| 93 | Early-life gut microbiome composition and milk allergy resolution | 6.2 | 384 | Citations (PDF) |
| 94 | Mass cytometry profiling the response of basophils and the complete peripheral blood compartment to peanut | 6.2 | 33 | Citations (PDF) |
| 95 | Food allergy: Past, present and future | 4.9 | 99 | Citations (PDF) |
| 96 | World Allergy Organization-McMaster University Guidelines for Allergic Disease Prevention (GLAD-P): Prebiotics | 4.0 | 145 | Citations (PDF) |
| 97 | World Allergy Organization-McMaster University Guidelines for Allergic Disease Prevention (GLAD-P): Vitamin D | 4.0 | 44 | Citations (PDF) |
| 98 | A randomized, double-blind, placebo-controlled study of omalizumab combined with oral immunotherapy for the treatment of cow's milk allergy | 6.2 | 357 | Citations (PDF) |
| 99 | Peanut T-cell epitope discovery: Ara h 1 | 6.2 | 46 | Citations (PDF) |
| 100 | Immunotherapy using algal‐produced Ara h 1 core domain suppresses peanut allergy in mice | 8.8 | 23 | Citations (PDF) |
| 101 | International Consensus on Allergen Immunotherapy II: Mechanisms, standardization, and pharmacoeconomics | 6.2 | 218 | Citations (PDF) |
| 102 | Reply | 6.2 | 0 | Citations (PDF) |
| 103 | Impact of Allergic Reactions on Food-Specific IgE Concentrations and Skin Test Results | 3.3 | 22 | Citations (PDF) |
| 104 | Sensitization phenotypes based on protein groups and associations to allergic diseases in children | 6.2 | 11 | Citations (PDF) |
| 105 | Kiwifruit Allergy in Children: Characterization of Main Allergens and Patterns of Recognition | 1.7 | 18 | Citations (PDF) |
| 106 | Molecular Diagnosis of Shrimp Allergy: Efficiency of Several Allergens to Predict Clinical Reactivity | 3.3 | 122 | Citations (PDF) |
| 107 | Casein-related anaphylaxis after use of an Everlast kickboxing glove | 6.2 | 4 | Citations (PDF) |
| 108 | Atopic dermatitis increases the effect of exposure to peanut antigen in dust on peanut sensitization and likely peanut allergy | 6.2 | 324 | Citations (PDF) |
| 109 | Profile of a milk-allergic patient who tolerated partially hydrolyzed whey formula | 3.3 | 3 | Citations (PDF) |
| 110 | Epinephrine Use in Positive Oral Food Challenges Performed as a Screening Test for Food Allergy Therapy Trials | 3.3 | 27 | Citations (PDF) |
| 111 | World Allergy Organization-McMaster University Guidelines for Allergic Disease Prevention (GLAD-P): Probiotics | 4.0 | 381 | Citations (PDF) |
| 112 | Sublingual immunotherapy for peanut allergy: Long-term follow-up of a randomized multicenter trial | 6.2 | 178 | Citations (PDF) |
| 113 | Consensus communication on early peanut introduction and the prevention of peanut allergy in high-risk infants | 6.2 | 174 | Citations (PDF) |
| 114 | Efficacy of baked milk oral immunotherapy in baked milk–reactive allergic patients | 6.2 | 103 | Citations (PDF) |
| 115 | Clinical reactivity to soy is best identified by component testing to Gly m 8 | 3.3 | 25 | Citations (PDF) |
| 116 | Anaphylaxis in America: A national physician survey | 6.2 | 35 | Citations (PDF) |
| 117 | Safety, clinical, and immunologic efficacy of a Chinese herbal medicine (Food Allergy Herbal Formula-2) for food allergy | 6.2 | 83 | Citations (PDF) |
| 118 | High similarity between lentil and other lentil-like-proteins (dal) complicates recommendations on avoidance in lentil allergic patients | 3.3 | 4 | Citations (PDF) |
| 119 | Anaphylaxis: Unique aspects of clinical diagnosis and management in infants (birth to age 2 years) | 6.2 | 128 | Citations (PDF) |
| 120 | Skin exposure promotes a Th2-dependent sensitization to peanut allergens | 10.7 | 200 | Citations (PDF) |
| 121 | Egg‐white‐specific <scp>I</scp>g<scp>A</scp> and <scp>I</scp>g<scp>A</scp>2 antibodies in egg‐allergic children: Is there a role in tolerance induction? | 2.8 | 48 | Citations (PDF) |
| 122 | Food allergy: Epidemiology, pathogenesis, diagnosis, and treatment | 6.2 | 1,182 | Citations (PDF) |
| 123 | Potential non‐T cells source of interleukin‐4 in food allergy | 2.8 | 11 | Citations (PDF) |
| 124 | Use of IgE and IgG4 epitope binding to predict the outcome of oral immunotherapy in cow's milk allergy | 2.8 | 62 | Citations (PDF) |
| 125 | Winter birth in inner-city asthmatic children is associated with increased food allergen sensitization risk | 6.2 | 4 | Citations (PDF) |
| 126 | Effect of heat treatment on milk and egg proteins allergenicity | 2.8 | 173 | Citations (PDF) |
| 127 | Precautionary labelling of foods for allergen content: are we ready for a global framework? | 4.0 | 148 | Citations (PDF) |
| 128 | Anaphylaxis in America: The prevalence and characteristics of anaphylaxis in the United States | 6.2 | 357 | Citations (PDF) |
| 129 | Berberine and limonin suppress IgE production by human B cells and peripheral blood mononuclear cells from food-allergic patients | 1.1 | 50 | Citations (PDF) |
| 130 | Relationship of IgE to basophil phenotypes in peanut-sensitized adults | 6.2 | 6 | Citations (PDF) |
| 131 | The natural history of egg allergy in an observational cohort | 6.2 | 259 | Citations (PDF) |
| 132 | Mapping of IgE epitopes in in vitro gastroduodenal digests of β-lactoglobulin produced with human and simulated fluids | 7.4 | 31 | Citations (PDF) |
| 133 | Clinical reactivity to hazelnut may be better identified by component testing than traditional testing methods | 3.3 | 51 | Citations (PDF) |
| 134 | Clinical features and resolution of food protein–induced enterocolitis syndrome: 10-year experience | 6.2 | 339 | Citations (PDF) |
| 135 | Intestinal permeability in children with food allergy on specific elimination diets | 2.8 | 86 | Citations (PDF) |
| 136 | The natural history of milk allergy in an observational cohort | 6.2 | 372 | Citations (PDF) |
| 137 | Peanut Oral Immunotherapy: Is It Ready for Clinical Practice? | 3.3 | 80 | Citations (PDF) |
| 138 | The Utility of Peanut Components in the Diagnosis of IgE-Mediated Peanut Allergy Among Distinct Populations | 3.3 | 92 | Citations (PDF) |
| 139 | Food allergy: an enigmatic epidemic | 10.6 | 94 | Citations (PDF) |
| 140 | Basophil reactivity, wheal size, and immunoglobulin levels distinguish degrees of cow's milk tolerance | 6.2 | 147 | Citations (PDF) |
| 141 | Utility of casein-specific IgE levels in predicting reactivity to baked milk | 6.2 | 137 | Citations (PDF) |
| 142 | Peanut oral immunotherapy modifies IgE and IgG4 responses to major peanut allergens | 6.2 | 195 | Citations (PDF) |
| 143 | Sublingual immunotherapy for peanut allergy: A randomized, double-blind, placebo-controlled multicenter trial | 6.2 | 287 | Citations (PDF) |
| 144 | Allergic Reactions to Foods in Preschool-Aged Children in a Prospective Observational Food Allergy Study | 4.7 | 246 | Citations (PDF) |
| 145 | Oral Immunotherapy for Treatment of Egg Allergy in Children | 43.7 | 660 | Citations (PDF) |
| 146 | Significance of ovomucoid- and ovalbumin-specific IgE/IgG4 ratios in egg allergy | 6.2 | 121 | Citations (PDF) |
| 147 | ICON: Food allergy | 6.2 | 571 | Citations (PDF) |
| 148 | A bioinformatics approach to identify patients with symptomatic peanut allergy using peptide microarray immunoassay | 6.2 | 94 | Citations (PDF) |
| 149 | Dietary baked egg accelerates resolution of egg allergy in children | 6.2 | 270 | Citations (PDF) |
| 150 | Standardizing double-blind, placebo-controlled oral food challenges: American Academy of Allergy, Asthma & Immunology–European Academy of Allergy and Clinical Immunology PRACTALL consensus report | 6.2 | 701 | Citations (PDF) |
| 151 | Beyond Skin Testing: State of the Art and New Horizons in Food Allergy Diagnostic Testing | 2.1 | 26 | Citations (PDF) |
| 152 | Efficacy and immunological actions of FAHF-2 in a murine model of multiple food allergies | 1.1 | 36 | Citations (PDF) |
| 153 | Treatments for food allergy: how close are we? | 2.8 | 24 | Citations (PDF) |
| 154 | NIAID-Sponsored 2010 Guidelines for Managing Food Allergy: Applications in the Pediatric Population | 4.7 | 130 | Citations (PDF) |
| 155 | Cloning and Characterization of 2S Albumin, Car i 1, a Major Allergen in Pecan | 6.0 | 33 | Citations (PDF) |
| 156 | Cloning and Characterization of an 11S Legumin, Car i 4, a Major Allergen in Pecan | 6.0 | 43 | Citations (PDF) |
| 157 | Peanut allergy: Clinical and immunologic differences among patients from 3 different geographic regions | 6.2 | 275 | Citations (PDF) |
| 158 | Future therapies for food allergies | 6.2 | 228 | Citations (PDF) |
| 159 | A phase II, randomized, double‑blind, parallel‑group, placebo‑controlled oral food challenge trial of Xolair (omalizumab) in peanut allergy | 6.2 | 267 | Citations (PDF) |
| 160 | Eosinophilic esophagitis: Updated consensus recommendations for children and adults | 6.2 | 1,972 | Citations (PDF) |
| 161 | Dietary baked milk accelerates the resolution of cow’s milk allergy in children | 6.2 | 393 | Citations (PDF) |
| 162 | Anaphylaxis to diphtheria, tetanus, and pertussis vaccines among children with cow’s milk allergy | 6.2 | 78 | Citations (PDF) |
| 163 | Clinical safety of Food Allergy Herbal Formula-2 (FAHF-2) and inhibitory effect on basophils from patients with food allergy: Extended phase I study | 6.2 | 80 | Citations (PDF) |
| 164 | World Allergy Organization (WAO) Diagnosis and Rationale for Action against Cow's Milk Allergy (DRACMA) Guidelines | 4.0 | 323 | Citations (PDF) |
| 165 | Food allergy | 6.2 | 976 | Citations (PDF) |
| 166 | Correlation of IgE/IgG4 milk epitopes and affinity of milk-specific IgE antibodies with different phenotypes of clinical milk allergy | 6.2 | 196 | Citations (PDF) |
| 167 | Immunologic features of infants with milk or egg allergy enrolled in an observational study (Consortium of Food Allergy Research) of food allergy | 6.2 | 97 | Citations (PDF) |
| 168 | Greater epitope recognition of shrimp allergens by children than by adults suggests that shrimp sensitization decreases with age | 6.2 | 148 | Citations (PDF) |
| 169 | Early recovery from cow's milk allergy is associated with decreasing IgE and increasing IgG4 binding to cow's milk epitopes | 6.2 | 146 | Citations (PDF) |
| 170 | US prevalence of self-reported peanut, tree nut, and sesame allergy: 11-year follow-up | 6.2 | 883 | Citations (PDF) |
| 171 | Reply | 6.2 | 1 | Citations (PDF) |
| 172 | Oral peanut immunotherapy in children with peanut anaphylaxis | 6.2 | 367 | Citations (PDF) |
| 173 | Peanut oral immunotherapy is not ready for clinical use | 6.2 | 100 | Citations (PDF) |
| 174 | Identification of IgE sequential epitopes of lentil (Len c 1) by means of peptide microarray immunoassay | 6.2 | 53 | Citations (PDF) |
| 175 | Guidelines for the Diagnosis and Management of Food Allergy in the United States: Summary of the NIAID-Sponsored Expert Panel Report | 6.2 | 1,735 | Citations (PDF) |
| 176 | Diagnosis and Rationale for Action against Cow's Milk Allergy (DRACMA): A summary report | 6.2 | 233 | Citations (PDF) |
| 177 | Safety, tolerability, and immunologic effects of a food allergy herbal formula in food allergic individuals: a randomized, double-blinded, placebo-controlled, dose escalation, phase 1 study | 1.1 | 89 | Citations (PDF) |
| 178 | Linear IgE-epitope mapping and comparative structural homology modeling of hazelnut and English walnut 11S globulins | 2.3 | 49 | Citations (PDF) |
| 179 | Association of allergen-specific regulatory T cells with the onset of clinical tolerance to milk protein | 6.2 | 237 | Citations (PDF) |
| 180 | Food Allergy Herbal Formula-2 silences peanut-induced anaphylaxis for a prolonged posttreatment period via IFN-γ–producing CD8+ T cells | 6.2 | 116 | Citations (PDF) |
| 181 | Allergen-specific basophil suppression associated with clinical tolerance in patients with milk allergy | 6.2 | 130 | Citations (PDF) |
| 182 | Epinephrine treatment is infrequent and biphasic reactions are rare in food-induced reactions during oral food challenges in children | 6.2 | 86 | Citations (PDF) |
| 183 | Food Allergy: Recent Advances in Pathophysiology and Treatment | 19.5 | 222 | Citations (PDF) |
| 184 | Development of a novel peptide microarray for large-scale epitope mapping of food allergens | 6.2 | 126 | Citations (PDF) |
| 185 | The role of immunoglobulin E-binding epitopes in the characterization of food allergy | 2.4 | 90 | Citations (PDF) |
| 186 | New visions for food allergy: An iPAC summary and future trends | 2.8 | 42 | Citations (PDF) |
| 187 | Peanut epitopes for IgE and IgG4 in peanut-sensitized children in relation to severity of peanut allergy | 6.2 | 221 | Citations (PDF) |
| 188 | Correlation of serum allergy (IgE) tests performed by different assay systems | 6.2 | 170 | Citations (PDF) |
| 189 | The use of serum-specific IgE measurements for the diagnosis of peanut, tree nut, and seed allergy | 6.2 | 251 | Citations (PDF) |
| 190 | Use of multiple doses of epinephrine in food-induced anaphylaxis in children | 6.2 | 154 | Citations (PDF) |
| 191 | Tolerance to extensively heated milk in children with cow's milk allergy | 6.2 | 505 | Citations (PDF) |
| 192 | The role of wheat ω-5 gliadin IgE antibodies as a diagnostic tool for wheat allergy in childhood | 6.2 | 35 | Citations (PDF) |
| 193 | Myosin light chain is a novel shrimp allergen, Lit v 3 | 6.2 | 203 | Citations (PDF) |
| 194 | Immunologic changes in children with egg allergy ingesting extensively heated egg | 6.2 | 447 | Citations (PDF) |
| 195 | Anaphylaxis epidemic: Fact or fiction? | 6.2 | 90 | Citations (PDF) |
| 196 | Mapping of the IgE and IgG4 sequential epitopes of milk allergens with a peptide microarray–based immunoassay | 6.2 | 193 | Citations (PDF) |
| 197 | Further fatalities caused by anaphylactic reactions to food, 2001-2006 | 6.2 | 899 | Citations (PDF) |
| 198 | Identification of 2 new sesame seed allergens: Ses i 6 and Ses i 7 | 6.2 | 67 | Citations (PDF) |
| 199 | Peanut allergy: Emerging concepts and approaches for an apparent epidemic | 6.2 | 312 | Citations (PDF) |
| 200 | Food anaphylaxis | 2.5 | 135 | Citations (PDF) |
| 201 | Adverse Reactions to Foods | 3.4 | 96 | Citations (PDF) |
| 202 | Second symposium on the definition and management of anaphylaxis: Summary report—Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium | 6.2 | 2,053 | Citations (PDF) |
| 203 | Skin prick test to egg white provides additional diagnostic utility to serum egg white–specific IgE antibody concentration in children | 6.2 | 94 | Citations (PDF) |
| 204 | Predictive value of skin prick tests using recombinant allergens for diagnosis of peanut allergy | 6.2 | 212 | Citations (PDF) |
| 205 | Nutrition in Infant Allergy | 0.5 | 0 | Citations (PDF) |
| 206 | Anaphylaxis: Persistent enigma | 1.0 | 3 | Citations (PDF) |
| 207 | Second Symposium on the Definition and Management of Anaphylaxis: Summary Report—Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network Symposium | 1.1 | 518 | Citations (PDF) |
| 208 | The Major Glycoprotein Allergen from <i>Arachis hypogaea</i>, Ara h 1, Is a Ligand of Dendritic Cell-Specific ICAM-Grabbing Nonintegrin and Acts as a Th2 Adjuvant In Vitro | 0.6 | 255 | Citations (PDF) |
| 209 | Allergenic characteristics of a modified peanut allergen | 4.1 | 80 | Citations (PDF) |
| 210 | The Chinese herbal medicine formula FAHF-2 completely blocks anaphylactic reactions in a murine model of peanut allergy | 6.2 | 213 | Citations (PDF) |
| 211 | Food allergy: When mucosal immunity goes wrong | 6.2 | 45 | Citations (PDF) |
| 212 | Symposium on the Definition and Management of Anaphylaxis: Summary report | 6.2 | 451 | Citations (PDF) |
| 213 | Ana o 3, an important cashew nut (Anacardium occidentale L.) allergen of the 2S albumin family | 6.2 | 133 | Citations (PDF) |
| 214 | IgE-binding peptides coupled to a commercial matrix as a diagnostic instrument for persistent cow's milk allergy | 6.2 | 53 | Citations (PDF) |
| 215 | IgE and IgG4 epitope mapping by microarray immunoassay reveals the diversity of immune response to the peanut allergen, Ara h 2 | 6.2 | 194 | Citations (PDF) |
| 216 | Food allergy therapy | 2.1 | 14 | Citations (PDF) |
| 217 | Contamination of dry powder inhalers for asthma with milk proteins containing lactose | 6.2 | 78 | Citations (PDF) |
| 218 | Update on food allergy☆ | 6.2 | 1,244 | Citations (PDF) |
| 219 | Prevalence of seafood allergy in the United States determined by a random telephone survey | 6.2 | 508 | Citations (PDF) |
| 220 | Soy immunotherapy for peanut-allergic mice: Modulation of the peanut-allergic response | 6.2 | 69 | Citations (PDF) |
| 221 | Microarray immunoassay: Association of clinical history, in vitro IgE function, and heterogeneity of allergenic peanut epitopes | 6.2 | 332 | Citations (PDF) |
| 222 | Persistent protective effect of heat-killed Escherichia coli producing “engineered,” recombinant peanut proteins in a murine model of peanut allergy | 6.2 | 192 | Citations (PDF) |
| 223 | Prevalence of peanut and tree nut allergy in the United States determined by means of a random digit dial telephone survey | 6.2 | 713 | Citations (PDF) |
| 224 | Effect of Anti-IgE Therapy in Patients with Peanut Allergy | 43.7 | 690 | Citations (PDF) |
| 225 | The evaluation and management of food allergy in atopic dermatitis | 1.5 | 86 | Citations (PDF) |
| 226 | Genetic susceptibility to food allergy is linked to differential TH2-TH1 responses in C3H/HeJ and BALB/c mice | 6.2 | 149 | Citations (PDF) |
| 227 | Measurement of peptide-specific IgE as an additional tool in identifying patients with clinical reactivity to peanuts | 6.2 | 145 | Citations (PDF) |
| 228 | Engineered Recombinant Peanut Protein and Heat-Killed <i>Listeria monocytogenes</i> Coadministration Protects Against Peanut-Induced Anaphylaxis in a Murine Model | 0.6 | 144 | Citations (PDF) |
| 229 | Food Protein-Induced Enterocolitis Syndrome Caused by Solid Food Proteins | 4.7 | 334 | Citations (PDF) |
| 230 | Improving in-vitro tests for the diagnosis of food hypersensitivity | 2.4 | 29 | Citations (PDF) |
| 231 | Immunotherapy for peanut allergy using modified allergens and a bacterial adjuvant | 6.2 | 3 | Citations (PDF) |
| 232 | Use of a peptide microarray immunoassay for the analysis of IgE-binding epitopes of major peanut allergens | 6.2 | 4 | Citations (PDF) |
| 233 | Immunotherapy with modified peanut allergens in a murine model of peanut allergy | 6.2 | 17 | Citations (PDF) |
| 234 | Human milk–specific mucosal lymphocytes of the gastrointestinal tract display a TH2 cytokine profile | 6.2 | 136 | Citations (PDF) |
| 235 | Milk-induced urticaria is associated with the expansion of T cells expressing cutaneous lymphocyte antigen | 6.2 | 39 | Citations (PDF) |
| 236 | Identification of sesame seed allergens by 2-dimensional proteomics and Edman sequencing: Seed storage proteins as common food allergens | 6.2 | 215 | Citations (PDF) |
| 237 | B-cell epitopes as a screening instrument for persistent cow's milk allergy | 6.2 | 243 | Citations (PDF) |
| 238 | Peanut Allergy | 43.7 | 159 | Citations (PDF) |
| 239 | Fatalities due to anaphylactic reactions to foods | 6.2 | 1,514 | Citations (PDF) |
| 240 | The natural history of peanut allergy | 6.2 | 560 | Citations (PDF) |
| 241 | Identification of IgE- and IgG-binding epitopes on αs1-casein: Differences in patients with persistent and transient cow's milk allergy | 6.2 | 289 | Citations (PDF) |
| 242 | Murine model of atopic dermatitis associated with food hypersensitivity | 6.2 | 111 | Citations (PDF) |
| 243 | Effects of cooking methods on peanut allergenicity | 6.2 | 460 | Citations (PDF) |
| 244 | A voluntary registry for peanut and tree nut allergy: Characteristics of the first 5149 registrants☆ | 6.2 | 356 | Citations (PDF) |
| 245 | Food Allergy Herbal Formula-1 (FAHF-1) blocks peanut-induced anaphylaxis in a murine model | 6.2 | 165 | Citations (PDF) |
| 246 | Hypoallergenicity and efficacy of an amino acid–based formula in children with cow’s milk and multiple food hypersensitivities | 2.0 | 90 | Citations (PDF) |
| 247 | Utility of food-specific IgE concentrations in predicting symptomatic food allergy | 6.2 | 1,302 | Citations (PDF) |
| 248 | Food Allergy: From Biology Toward Therapy | 1.1 | 7 | Citations (PDF) |
| 249 | Dose-response in double-blind, placebo-controlled oral food challenges in children with atopic dermatitis | 6.2 | 245 | Citations (PDF) |
| 250 | Quantitative IgE antibody assays in allergic diseases | 6.2 | 155 | Citations (PDF) |
| 251 | A murine model of peanut anaphylaxis: T- and B-cell responses to a major peanut allergen mimic human responses | 6.2 | 418 | Citations (PDF) |
| 252 | Genetics of peanut allergy: A twin study | 6.2 | 276 | Citations (PDF) |
| 253 | The Chinese herbal medicine formula MSSM-002 suppresses allergic airway hyperreactivity and modulates TH1/TH2 responses in a murine model of allergic asthma | 6.2 | 90 | Citations (PDF) |
| 254 | Letter to the Editor | 2.8 | 0 | Citations (PDF) |
| 255 | Anaphylaxis and food allergy | 10.6 | 24 | Citations (PDF) |
| 256 | Self-reported allergic reactions to peanut on commercial airliners☆☆☆ | 6.2 | 155 | Citations (PDF) |
| 257 | Food allergy. Part 2: Diagnosis and management | 6.2 | 452 | Citations (PDF) |
| 258 | Prevalence of peanut and tree nut allergy in the US determined by a random digit dial telephone survey | 6.2 | 462 | Citations (PDF) |
| 259 | Food allergy. Part 1: Immunopathogenesis and clinical disorders | 6.2 | 770 | Citations (PDF) |
| 260 | A murine model of IgE-mediated cow’s milk hypersensitivity | 6.2 | 351 | Citations (PDF) |
| 261 | Molecular cloning and epitope analysis of the peanut allergen Ara h 3 | 10.7 | 356 | Citations (PDF) |
| 262 | Interpreting skin prick tests in the evaluation of food allergy in children | 2.8 | 175 | Citations (PDF) |
| 263 | Clinical features of food protein–induced enterocolitis syndrome | 2.0 | 364 | Citations (PDF) |
| 264 | Prevalence of IgE-Mediated Food Allergy Among Children With Atopic Dermatitis | 4.7 | 528 | Citations (PDF) |
| 265 | Clinical Features of Acute Allergic Reactions to Peanut and Tree Nuts in Children | 4.7 | 419 | Citations (PDF) |
| 266 | Relationship between food-specific IgE concentrations and the risk of positive food challenges in children and adolescents | 6.2 | 999 | Citations (PDF) |
| 267 | Identification and Mutational Analysis of the Immunodominant IgE Binding Epitopes of the Major Peanut AllergenAra h 2 | 2.9 | 368 | Citations (PDF) |
| 268 | Food Sensitivity and the Pathogenesis of Atopic Dermatitis | 2.2 | 48 | Citations (PDF) |
| 269 | Eosinophilic esophagitis attributed to gastroesophageal reflux: Improvement with an amino acid-based formula | 1.0 | 1,074 | Citations (PDF) |
| 270 | Allergenicity and antigenicity of chicken egg ovomucoid (Gal d III) compared with ovalbumin (Gal d I) in children with egg allergy and in mice | 6.2 | 253 | Citations (PDF) |
| 271 | Skin testing with natural foods in patients suspected of having food allergies: Is it a necessity? | 6.2 | 91 | Citations (PDF) |
| 272 | Immunologic changes associated with the development of tolerance in children with cow milk allergy | 2.0 | 120 | Citations (PDF) |
| 273 | Fatal and Near-Fatal Anaphylactic Reactions to Food in Children and Adolescents | 43.7 | 1,634 | Citations (PDF) |
| 274 | Food Hypersensitivity and Dietary Management in Atopic Dermatitis | 1.1 | 10 | Citations (PDF) |
| 275 | Anaphylactic reactions to a psyllium-containing cereal | 6.2 | 38 | Citations (PDF) |
| 276 | Allergic Reactions to Milk-Contaminated “Nondairy” Products | 43.7 | 147 | Citations (PDF) |
| 277 | Allergenicity of Orally Administered Immunoglobulin Preparations in Food-Allergic Children | 4.7 | 39 | Citations (PDF) |
| 278 | Psychological and social factors of atopic dermatitis | 9.5 | 22 | Citations (PDF) |
| 279 | Natural history of food hypersensitivity in children with atopic dermatitis | 2.0 | 326 | Citations (PDF) |
| 280 | Spontaneous Release of Histamine from Basophils and Histamine-Releasing Factor in Patients with Atopic Dermatitis and Food Hypersensitivity | 43.7 | 279 | Citations (PDF) |
| 281 | Double-blind, placebo-controlled food challenge (DBPCFC) as an office procedure: A manual | 6.2 | 690 | Citations (PDF) |
| 282 | The role of food allergy and mediator release in atopic dermatitis | 6.2 | 214 | Citations (PDF) |
| 283 | Dermal Deposition of Eosinophil-Granule Major Basic Protein in Atopic Dermatitis | 43.7 | 415 | Citations (PDF) |
| 284 | Food hypersensitivity and atopic dermatitis: Evaluation of 113 patients | 2.0 | 707 | Citations (PDF) |
| 285 | Increased Plasma Histamine Concentrations after Food Challenges in Children with Atopic Dermatitis | 43.7 | 251 | Citations (PDF) |
